Statins and Prostate Cancer: The Search for the Magic Bullet
Do statins lower your risk of getting aggressive prostate cancer? Well, they may. Study after study hints at a tantalizing connection between taking these cholesterol-lowering drugs and protection from getting...Read More
The Prostate Cancer Foundation Honors Family And Caregivers During February With The True Love Contest
SANTA MONICA, CA, January 31, 2018 – Starting February 1st, the Prostate Cancer Foundation (PCF) will kick-off a month-long TRUE Love contest that honors family and caregivers for their tireless...Read More
The Prostate Cancer Foundation Awards Unprecedented Number of New Research Grants
SANTA MONICA, Calif., January 23, 2018 – Celebrating its 25th year as the global leader in driving cutting-edge research leading to treatments and cures for prostate cancer, the Prostate Cancer...Read More
Cleveland Clinic researchers find new gene variant linked to deadly prostate cancer
Jan. 17 2018, Cleveland: Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer. The research, led by Nima...Read More
$2.5 Million Gift from Robert Frederick Smith to the Prostate Cancer Foundation is the Largest Donation Ever Dedicated to Advancing Prostate Cancer Research in African-American Men
SANTA MONICA, CA Jan. 14, 2018 – Helping to advance revolutionary research in prostate cancer, Robert F. Smith, Founder, Chairman and CEO of Vista Equity Partners, has donated $2.5 million...Read More
Star-Studded Album Honoring Dan Fogelberg Will Benefit the Prostate Cancer Foundation
LOS ANGELES, November 21, 2017 - The highly-anticipated album, A Tribute to Dan Fogelberg, is now available on CD, digital and streaming platforms. Released worldwide through BMG, sales will benefit the Prostate...Read More
PCF-Funded Researchers at the Cleveland Clinic Reveal Biomarker for Guiding Prostate Cancer Treatment
October 12, 2017, Cleveland: Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies....Read More
Prostate Cancer Foundation Announces 2017 PCF Challenge Awards to Accelerate the Development of New Treatments for Advanced Prostate Cancer
WASHINGTON, D.C., October 5, 2017 – The Prostate Cancer Foundation (PCF) today announced awards totaling $7.5 million to fund new 2017 PCF Challenge Awards supporting international, cross-disciplinary teams of investigators...Read More
New Biomarker Predicts Metastatic Prostate Cancers
Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are prone to becoming aggressive and spreading...Read More
The Prostate Cancer Foundation, in Collaboration With World’s Leading Researchers, Publish Standard Setting Comprehensive Patient Guide
Guide Offers Recommendations on Newest Life-Extending Treatments for Men with Metastatic Prostate Cancer and their Families LOS ANGELES, CA, September 14, 2017 – The Prostate Cancer Foundation, in honor of Prostate...Read More